Login

MEDAMI 2022 - Multimodality molecular neuro-imaging: clinical and technical state-of-the-art

4–7 Sept 2022
Europe/Zurich timezone

Session

Introduction / degeneration / addiction / trauma

Session 1
5 Sept 2022, 08:30

Conveners

Introduction / degeneration / addiction / trauma

  • Peter Krizan

Presentation materials

There are no materials yet.

  1. 1. Introduction
    Vesna Sossi (University of British Columbia)
    05/09/2022, 08:30
    Degeneration, Addiction And Trauma
    Invited
  2. 14. Multimodality in the context of understanding of brain function in psychiatry/addiction
    Ilan Rabiner (King's College London)
    05/09/2022, 08:40
    Degeneration, Addiction And Trauma
    Invited
  3. 17. X-Ray Darkfield Imaging - Basic Physics & First Clinical Results for COVID-19
    Franz Pfeiffer (Technical University of Munich)
    05/09/2022, 09:10
    Degeneration, Addiction And Trauma
    Invited
  4. 3. Biomarkers for Neurodegeneration with a focus on Alzheimer’s and Parkinson’s Disease
    Gunn Roger (Imperial College London)
    05/09/2022, 09:40
    Tracers and other modalities
    Invited

    Alzheimer's and Parkinson's disease represent two of the most prevalent neurodegenerative diseases with dramatic socio-economic impacts for governments and healthcare systems to address. Currently, excepting the modest effects of Aducanumab in AD, there are no disease modifying therapies for either disease. However, the development of future disease modifying drugs represents a tremendously...

    Go to contribution page
Building timetable...